The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatitis B surface antigen produced by a human hepatoma cell line
MacNab, G. M., Alexander, J. J., Lecatsas, G., Bey, E. M., & Urbanowicz, J. M. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.205 · Cited by 311
Cited by
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Knowles, B. B., Howe, C. C., & Aden, D. P. (1980) · Science · doi:10.1126/science.6248960 · Cited by 2,025
Self-citationSelective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
“Hep3B cells are particularly appropriate for our studies because they lack p53 (30, 31, 41).”
Plasticity of the Differentiated State
Blau, H. M., Pavlath, G. K., Hardeman, E. C., Chiu, C.-P., Silberstein, L., Webster, S. G., Miller, S. C., & Webster, C. (1985) · Science · doi:10.1126/science.2414846 · Cited by 837
Andrews, P. W. (1984) · Developmental Biology · doi:10.1016/0012-1606(84)90316-6 · Cited by 806
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Primary structure and functional expression of rat and human stem cell factor DNAs
Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I. K., Jacobsen, F. W., Mendlaz, E. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90301-t · Cited by 728
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681
Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression
Okubo, K., Hori, N., Matoba, R., Niiyama, T., Fukushima, A., Kojima, Y., & Matsubara, K. (1992) · Nature Genetics · doi:10.1038/ng1192-173 · Cited by 522
Lecuit, M., Dramsi, S., Gottardi, C., Fedor-Chaiken, M., Gumbiner, B., & Cossart, P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3956 · Cited by 497
Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3075 · Cited by 469
Friedman, A. D., Landschulz, W. H., & McKnight, S. L. (1989) · Genes & Development · doi:10.1101/gad.3.9.1314 · Cited by 464
Bartenschlager, R., Ahlborn-Laake, L., Mous, J., & Jacobsen, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3835-3844.1993 · Cited by 462
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
Bressac, B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., & Ozturk, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1973 · Cited by 416
Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens
Knasmüller, S., Parzefall, W., Sanyal, R., Ecker, S., Schwab, C., Uhl, M., Mersch-Sundermann, V., Williamson, G., Hietsch, G., Langer, T., et al. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00297-2 · Cited by 415
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Arzumanian, V. A., Kiseleva, O. I., & Poverennaya, E. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313135 · Cited by 387
Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.
Bresnahan, P. A., Leduc, R., Thomas, L., Thorner, J., Gibson, H. L., Brake, A. J., Barr, P. J., & Thomas, G. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.2851 · Cited by 383
Darlington, G. J., Wilson, D. R., & Lachman, L. B. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.3.787 · Cited by 383
Structural organization of the hepatitis B virus minichromosome
Bock, C. T., Schwinn, S., Locarnini, S., Fyfe, J., Manns, M. P., Trautwein, C., & Zentgraf, H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4481 · Cited by 361
The regulated expression of erythropoietin by two human hepatoma cell lines.
Goldberg, M. A., Glass, G. A., Cunningham, J. M., & Bunn, H. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7972 · Cited by 357
Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids
Javitt, N. B. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.2.2153592 · Cited by 356
Culture and Functional Characterization of Human Hepatoma HepG2 Cells
Donato, M. T., Tolosa, L., & Gómez-Lechón, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2074-7_5 · Cited by 331
Nophar, Y., Kemper, O., Brakebusch, C., Englemann, H., Zwang, R., Aderka, D., Holtmann, H., & Wallach, D. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07526.x · Cited by 331
Hep G2 is a hepatoblastoma-derived cell line
López-Terrada, D., Cheung, S. W., Finegold, M. J., & Knowles, B. B. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.07.003 · Cited by 329
Self-citationCell Culture in 3-Dimensional Microfluidic Structure of PDMS (polydimethylsiloxane)
Leclerc, E., Sakai, Y., & Fujii, T. (2003) · Biomedical Microdevices · doi:10.1023/a:1024583026925 · Cited by 324
Mersch-Sundermann, V., Knasmüller, S., Wu, X.-J., Darroudi, F., & Kassie, F. (2004) · Toxicology · doi:10.1016/j.tox.2004.02.009 · Cited by 304
Regulation of the Erythropoietin Gene
Imagawa, S., Goldberg, M. A., & Bunn, H. F. (1989) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4613-0623-8_9 · Cited by 297
Three‐Dimensional Microfluidic Tissue‐Engineering Scaffolds Using a Flexible Biodegradable Polymer
Bettinger, C. J., Weinberg, E. J., Kulig, K. M., Vacanti, J. P., Wang, Y., Borenstein, J. T., & Langer, R. (2006) · Advanced Materials · doi:10.1002/adma.200500438 · Cited by 291
Hallenbeck, P. L., Chang, Y.-N., Hay, C., Golightly, D., Stewart, D., Lin, J., Phipps, S., & Chiang, Y. L. (1999) · Human Gene Therapy · doi:10.1089/10430349950017725 · Cited by 283
Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation
Bruning, U., Morales-Rodriguez, F., Kalucka, J., Goveia, J., Taverna, F., Queiroz, K. C. S., Dubois, C., Cantelmo, A. R., Chen, R., Loroch, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.019 · Cited by 282
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Elledge, S. J., & Spottswood, M. R. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07808.x · Cited by 263
Laron Dwarfism and Non-Insulin-Dependent Diabetes Mellitus in the Hnf-1 α Knockout Mouse
Lee, Y.-H., Sauer, B., & Gonzalez, F. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.3059 · Cited by 262
Myint, K., Biswas, R., Li, Y., Jong, N., Jamieson, S., Liu, J., Han, C., Squire, C., Merien, F., Lu, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38667-8 · Cited by 262
Gripon, P., Diot, C., Thézé, N., Fourel, I., Loreal, O., Brechot, C., & Guguen-Guillouzo, C. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4136-4143.1988 · Cited by 262
Alía, M., Mateos, R., Ramos, S., Lecumberri, E., Bravo, L., & Goya, L. (2006) · European Journal of Nutrition · doi:10.1007/s00394-005-0558-7 · Cited by 259
Quercetin protects human hepatoma HepG2 against oxidative stress induced by tert-butyl hydroperoxide
Alía, M., Ramos, S., Mateos, R., Granado-Serrano, A. B., Bravo, L., & Goya, L. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.07.014 · Cited by 258
Complement biosynthesis by the human hepatoma-derived cell line HepG2.
Morris, K. M., Aden, D. P., Knowles, B. B., & Colten, H. R. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110687 · Cited by 256
Self-citationVillani, G., Greco, M., Papa, S., & Attardi, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31829 · Cited by 225
(1994) · PubMed Central · Cited by 209
Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191
“U2OS Osteosarcoma cell line used for transient transfection experiments (Ponten and Saksela, 1967) Hep3B Hepatoblastoma (Aden et al., 1979) 786-O VHL Renal Clear Cell Carcinoma (RCC) (Williams et al.”
MethodFriedman, A. D., & McKnight, S. L. (1990) · Genes & Development · doi:10.1101/gad.4.8.1416 · Cited by 162
Bouma, M.-E., Rogier, E., Verthier, N., Labarre, C., & Feldmann, G. (1989) · In Vitro Cellular & Developmental Biology · doi:10.1007/bf02628465 · Cited by 130
Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation
Schippers, I. J., Moshage, H., Roelofsen, H., Müller, M., Heymans, H. S. A., Ruiters, M., & Kuipers, F. (1997) · Cell Biology and Toxicology · doi:10.1023/a:1007404028681 · Cited by 110
A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
Nagaya, T., Fujieda, M., Otsuka, G., Yang, J.-P., Okamoto, T., & Seo, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7771 · Cited by 107
Wilkening, S., & Bader, A. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10085 · Cited by 102
“Aden where the cell line was established [17].”
Liguori, M. J., Blomme, E. A. G., & Waring, J. F. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017608 · Cited by 84
“line, which was first established in 1979 (Aden et al., 1979).”
BackgroundLiver three-dimensional cellular models for high-throughput chemical testing
Yang, S., Ooka, M., Margolis, R. J., & Xia, M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100432 · Cited by 75
Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2
Zhou, B., Ho, S. S., Greer, S. U., Spies, N., Bell, J. M., Zhang, X., Zhu, X., Arthur, J. G., Byeon, S., Pattni, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz169 · Cited by 72
“It is a hepatoblastoma cell line derived from a 15-year-old male of European ancestry (4,5).”
BackgroundPreclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
Wolff, M., Fandrey, J., & Jelkmann, W. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.5.c1266 · Cited by 70
Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59
Fukuda, J., Okamura, K., Nakazawa, K., Ijima, H., Yamashita, Y., Shimada, M., Shirabe, K., Tsujita, E., Sugimachi, K., & Funatsu, K. (2003) · Cell Transplantation · doi:10.3727/000000003783985151 · Cited by 54
Induction of tubular peroxisomes by UV irradiation and reactive oxygen species in HepG2 cells
Schrader, M., Wodopia, R., & Fahimi H., D. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700906 · Cited by 51
Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines
Rolin, S., Amri, H. S.-E., Batt, A.-M., Levy, M., Bagrel, D., & Siest, G. (1989) · Cell Biology and Toxicology · doi:10.1007/bf00141060 · Cited by 51
Dig1 protects against cell death provoked by glyphosate-based herbicides in human liver cell lines
Gasnier, C., Benachour, N., Clair, E., Travert, C., Langlois, F., Laurant, C., Decroix-Laporte, C., & Séralini, G.-E. (2010) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-5-29 · Cited by 49
Application of In Vitro Metabolism Activation in High-Throughput Screening
Ooka, M., Lynch, C., & Xia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218182 · Cited by 49
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity
Daemer, R. J., Feinstone, S. M., Alexander, J. J., Tully, J. G., London, W. T., Wong, D. C., & Purcell, R. H. (1980) · Infection and Immunity · doi:10.1128/iai.30.2.607-611.1980 · Cited by 31
Fuyuki, I., Galbraith, R. A., & Sassa, S. (1990) · International Journal of Biochemistry · doi:10.1016/0020-711x(90)90344-3 · Cited by 24
Advancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22
Twin studies advance the understanding of gene-environment interplay in human nutrigenomics
Pallister, T., Spector, T. D., & Menni, C. (2014) · Nutrition Research Reviews · doi:10.1017/s095442241400016x · Cited by 20
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
Gatzios, A., Rombaut, M., Buyl, K., De Kock, J., Rodrigues, R. M., Rogiers, V., Vanhaecke, T., & Boeckmans, J. (2022) · Biomedicines · doi:10.3390/biomedicines10010161 · Cited by 15
“Furthermore, commonly used human hepatic cell lines originate from sources from different sexes: HepG2 cells were isolated in 1975 from a hepatocellular blastoma from a 15-year old boy [39], whereas HepaRG cells were isolated from a HCC of a female patient [40].”
BackgroundSystematic elucidation of genetic mechanisms underlying cholesterol uptake
Hamilton, M. C., Fife, J. D., Akinci, E., Yu, T., Khowpinitchai, B., Cha, M., Barkal, S., Thi, T. T., Yeo, G. H. T., Ramos Barroso, J. P., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100304 · Cited by 16
Established Liver Cell Lines: Are You Sure to Have the Right Ones?
Weiskirchen, R. (2022) · Livers · doi:10.3390/livers2030015 · Cited by 12
“The human cell line HepG2 was originally classified as a hepatocellular carcinoma cell line derived from liver tissue of a 15-year-old white male with a well-differentiated hepatocellular carcinoma [28,29].”
BackgroundTanaka-yachi, R., Aizawa, K., Shimizu, K., Akutsu, H., & Nakamura, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-25777-z · Cited by 4
(1982) · PubMed
Metadata
- Authors
- Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I., & Knowles, B. B.
- Venue
- Nature
- Published
- 1979-12
- Volume
- 282
- Issue
- 5739
- Pages
- 615-616
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011257176
- Cited by
- 1,317
- References
- 1
- FWCI
- 16.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.